MLSS · Milestone Scientific Inc. · Proposed Sales
$0.31
+0.01 (+4.50%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred recurring operating losses and has an accumulated deficit. These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Management believes that existing cash resources, anticipated collections and potential financing proceeds may support near-term operations; however, additional financing is required, and there can be no assurance that such financing will be available on acceptable terms, or at all. Accordingly, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 13, 2026
Market Cap
$26.62M
Shares
88.74M
Volume · Oct 28
29.83K
Avg daily vol (3M)
119.42K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-09-09 | BP4 S.r.l. | 10% Stockholder | 400,000 | 2025-09-10 | Intesa San Paolo SPA |
| 2025-05-22 | BP4 S.r.l. (MLSS) | 10% Stockholder | 550,000 | 2025-05-23 | Intesa San Paolo SPA |
| 2024-12-19 | McGeehan Michael | Director | 46,879 | 2024-12-19 | Charles Schwab Corp |
| 2024-09-11 | McGeehan Michael | Director | 50,107 | 2024-09-11 | Charles Schwab Corp. |
| 2023-10-17 | Trombetta Gian Domenico | Director | 100,000 | 2023-10-24 | Intesa San Paolo SPA |
Showing 1–5 of 5 filings